Evidence map›Paper›PMID 42475502›Full record

ArticleBioinformatics (Oxford, England)2026

WxS-QC-a quality control pipeline for human germline short-variant Whole-Genome and Whole-Exome cohorts for population-scale analyses.

Gennadii Zakharov, Ruth Eberhardt, Alina Frolova, Dmytro Horyslavets, Eric Hidari, Iaroslav Popov, Joanna Dennehy, Mykhailo Koreshkov, Pavlos Antoniou, Valeriia Kantsypa and 2 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gennadii ZakharovWellcome Sanger Institute (WSI), Hinxton, Cambridgeshire CB10 1SA, United Kingdom.ORCID 0000-0003-4850-3777
Ruth EberhardtWellcome Sanger Institute (WSI), Hinxton, Cambridgeshire CB10 1SA, United Kingdom.ORCID 0000-0001-6152-1369
Alina FrolovaInstitute of Molecular Biology and Genetics of NASU (IMBG), Kyiv 03143, Ukraine.ORCID 0000-0001-5469-7366
Dmytro HoryslavetsInstitute of Molecular Biology and Genetics of NASU (IMBG), Kyiv 03143, Ukraine.ORCID 0000-0002-6780-0235
Eric HidariWellcome Sanger Institute (WSI), Hinxton, Cambridgeshire CB10 1SA, United Kingdom.ORCID 0000-0002-4777-5239
Iaroslav PopovWellcome Sanger Institute (WSI), Hinxton, Cambridgeshire CB10 1SA, United Kingdom.ORCID 0000-0001-7538-123X
Joanna DennehyWellcome Sanger Institute (WSI), Hinxton, Cambridgeshire CB10 1SA, United Kingdom.ORCID 0009-0004-5975-4349
Mykhailo KoreshkovInstitute of Molecular Biology and Genetics of NASU (IMBG), Kyiv 03143, Ukraine.
Pavlos AntoniouMars, Hansa Road, Hardwick Industrial Estate, Kings Lynn PE30 4JE, United Kingdom.
Valeriia KantsypaInstitute of Molecular Biology and Genetics of NASU (IMBG), Kyiv 03143, Ukraine.ORCID 0009-0003-5525-4892
Vladimir OvchinnikovWellcome Sanger Institute (WSI), Hinxton, Cambridgeshire CB10 1SA, United Kingdom.ORCID 0000-0003-0350-8478
Vivek IyerWellcome Sanger Institute (WSI), Hinxton, Cambridgeshire CB10 1SA, United Kingdom.ORCID 0000-0002-7536-0954

Funding

Research Collaboration Agreement L24-0442/0124U004344Wellcome TrustWellcome Trust 220540/Z/20/A
6 · The paper itself

Abstract

summaryWhole-exome (WES) and whole-genome (WGS) sequencing are rapidly becoming preferred methods for population-scale analysis of the human genetic landscape. However, there are currently no standardized quality control (QC) pipelines for human WES and WGS datasets. In this paper, we present WxS-QC, a powerful, scalable, and convenient pipeline for the QC of human germline short-variant WGS and WES cohorts for population-scale analyses. Our pipeline is suitable for both rare-variant discovery and common-variant association studies. It is based on deeply refactored gnomAD v3 and v4 quality control pipelines, contains several methods we have developed de novo, and is aligned with current best practices in WGS/WES germline cohort QC. We provide all methods in a single codebase, aligned to work together and controlled via a single YAML config, with automatic export of resulting graphs and summary tables, excellent performance and scalability, and comprehensive documentation. The pipeline can run in any UNIX-like environment and can efficiently process cohorts of up to 200 000 whole-exome samples, with the potential to handle bigger datasets. AVAILABILITY AND IMPLEMENTATION: The pipeline code is written in Python using the Hail library and is freely available under the BSD-3 license here: https://github.com/wtsi-hgi/wxs-qc. The detailed description of the pipeline is available in the pipeline documentation: https://github.com/wtsi-hgi/wxs-qc/blob/main/README.md. We also provide an open dataset with all required metadata, which is available at https://wxs-qc-data.cog.sanger.ac.uk/wxs-qc_public_dataset_v3.tar. An example of test dataset analysis is available in the supplementary materials.

Indexed as

ExomeExome SequencingGenome, HumanGerm-Line MutationSoftwareWhole Genome SequencingHumansQuality Control

Identifiers

PMID42475502
PMCPMC13412161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.